Ag Novartis, 10% Owner at Ra Pharmaceuticals, Inc. (RARX), sold 24,228 shares at $22.11 ($548K) on 2017-06-07, disclosed to the SEC on 2017-06-08.
Open-market sale of $548k RARX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.98 | 7,274 | $167K | 30.5% |
| 2 | $22.98 | 7,274 | $167K | 30.5% |
| 3 | $22.11 | 4,840 | $107K | 19.5% |
| 4 | $22.11 | 4,840 | $107K | 19.5% |
| Total | $22.63 avg | 24,228 | $548K | 100% |
| Filing → |
| GRTX | SELL | 2020-06-12 | $242K | — | Filing → |
| GRTX | BUY | 2019-11-12 | $3.0M | — | Filing → |
| ARPO | SELL | 2019-04-29 | $1.4M | — | Filing → |